title: Edoxaban: Efficacy, Laboratory Monitoring, and Approach to Reversal.
authors.affiliation: 1  Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut;
authors.forename: Eric A
authors.initials: EA
authors.lastname: Gehrie
authors.affiliation: 1  Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut;|2  Pathology & Laboratory Medicine Service, West Haven, Connecticut.
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Tormey
mesh_terms: D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D016903:Drug Monitoring; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D011725:Pyridines; D013844:Thiazoles; C025667:prothrombin complex concentrates; C552171:edoxaban